Advisory Board March 12, 2025
According to a new study published in JAMA Surgery, patients who took GLP-1 drugs before undergoing bariatric surgery did not see greater weight loss or other metabolic benefits compared to patients who only underwent surgery.
4 ways comprehensive obesity care can boost surgical services
Study details and key findings
For the study, researchers analyzed data from 182 patients who received the GLP-1 drug semaglutide before undergoing bariatric surgery between 2017 and 2024. These patients were also matched to 182 controls who did not take semaglutide before undergoing bariatric surgery.
The average age of patients at surgery was 45 years, 77.5% were female, and 74% were white. Both groups had comparable baseline median weights and BMIs. Most of the patients underwent...
Today's Sponsors
Today's Sponsor